Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer.

Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer.

Item
http://www.wikidata.org/entity/Q38846176
ω-3 free fatty acids and all-trans retinoic acid synergistically induce growth inhibition of three subtypes of breast cancer cell linesBreast Cancer Patients Have Greatly Benefited from the Progress in Molecular Oncology.Spatholobus suberectus Column Extract Inhibits Estrogen Receptor Positive Breast Cancer via Suppressing ER MAPK PI3K/AKT PathwayReview: Receptor Targeted Nuclear Imaging of Breast Cancer.Ribociclib for the treatment of advanced hormone receptor-positive, HER2-negative breast cancer.Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer.HR+, HER2- Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of action, Clinical Activity, and Safety Profiles.Long non-coding RNA00544 serves as a potential novel predictive and prognostic marker for HR+ HER2- subtype breast cancer.PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells.Role of Brf1 interaction with ERα, and significance of its overexpression, in human breast cancer.Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patients.The effect of aspirin on circulating tumor cells in metastatic colorectal and breast cancer patients: a phase II trial study.Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer.The efficacy and safety of targeted therapy plus fulvestrant in postmenopausal women with hormone-receptor positive advanced breast cancer: A meta-analysis of randomized-control trials
P2860

Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer.

Item
http://www.wikidata.org/entity/Q38846176
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer.
@en
type
label
Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer.
@en
prefLabel
Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer.
@en
P2093
P304
P31
P356
10.1016/J.DRUDIS.2016.05.012
P433
P478
P50
P577
P698